Moderna’s COVID-19 Vaccine Spurs Immune Response In All Phase I Subjects At All Doses

 
• By Mandy Jackson
  
3d rendering: Vaccination against new Corona Virus SARS-CoV-2: A glass with vaccination and a syringe behind it. The word vaccination in English, Spanish, French and German on the label. Copy space
Moderna's vaccine generated antibodies that can neutralize SARS-CoV-2 in all 45 Phase I participants • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D